He is responsible for the science that substantiates Imperial Brands' next generation products as potentially reduced harm relative to continued smoking and the stewardship of Imperials products. He leads a large multi-disciplined team of 200 people, and a laboratory network spread over several countries. Joe has 25 years experience in the science of tobacco & nicotine, risk assessment and regulatory affairs.

Joe serves on the Board of CORESTA (Cooperation Centre for Scientific Research Relative to Tobacco), a global organisation with over 170 company, institute, and laboratory members. CORESTA is an authoritative source of publicly available, credible science and best practices related to tobacco products.

Joe is a Fellow of the Royal Society of Medicine and a European Registered Toxicologist (ERT) with degrees in Toxicology and Physiology.